Stock data
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON) reported revenue of US$79.95M and net income of -US$4.60M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$79.95M | US$42.74M | -US$0.84M | -US$4.60M | — |
| 2024 | US$39.01M | US$23.41M | -US$2.60M | -US$3.82M | — |
| 2023 | US$31.64M | US$21.06M | -US$1.19M | -US$0.94M | — |
| 2022 | US$21.25M | US$14.32M | -US$8.26M | -US$9.02M | — |
| 2021 | US$21.83M | US$19.00M | -US$1.50M | -US$1.96M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$37.59M | US$11.58M | — |
| 2026-03-31 | US$24.27M | US$1.55M | — |
| 2025-12-31 | US$21.28M | US$1.48M | — |
| 2025-09-30 | US$22.46M | -US$1.93M | — |
| 2025-06-30 | US$18.93M | -US$2.58M | — |
| 2025-03-31 | US$17.28M | -US$1.57M | — |
| 2024-12-31 | US$11.65M | -US$0.60M | — |
| 2024-09-30 | US$10.32M | US$0.63M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.